![John Clarke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Clarke
Founder at The Baldwin & Clarke Cos.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Patrick T. Mooney | M | 55 |
Inpellis, Inc.
![]() Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | 9 years |
Harry G. McCoy | M | - |
Inpellis, Inc.
![]() Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | 9 years |
Frederic Jacques de Bure | M | 52 |
Inpellis, Inc.
![]() Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | 9 years |
David R. Staskin | M | - |
Inpellis, Inc.
![]() Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | 9 years |
Frank A. Manguso | M | - |
Inpellis, Inc.
![]() Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | 9 years |
Robert Keller | M | 86 |
Triumph Investment Managers LLC
![]() Triumph Investment Managers LLC Investment ManagersFinance Triumph Investment Managers LLC (Triumph Investment) is a private equity firm founded in 2003. The firm is headquartered in Bedford, New Hampshire. | 18 years |
Peter Clarke | M | 45 |
The Baldwin & Clarke Cos.
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Joseph Reilly | M | 67 |
Centerpoint Bank
![]() Centerpoint Bank Regional BanksFinance Centerpoint Bank operates as a commercial bank. The company is headquartered in Bedford, NH. | - |
Debra R. Hallett | F | - |
Centerpoint Bank
![]() Centerpoint Bank Regional BanksFinance Centerpoint Bank operates as a commercial bank. The company is headquartered in Bedford, NH. | 6 years |
Adam Drapczuk | M | 48 |
Inpellis, Inc.
![]() Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 10 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Clarke
- Personal Network